Fatores determinantes do câncer de mama : rastreamento e atraso no início do tratamento

• Autor(a) principal: Lopes, Tiara Cristina Romeiro
• Data de Publicação: 2016
• Tipo de documento: Tese
• Idioma: por
• Título da fonte: Repositório Institucional da Universidade Estadual de Maringá (RI-UEM)
• Texto Completo: http://repositorio.uem.br:8080/jspui/handle/1/1976
• topic: Neoplasias da mama; Rastreamento e diagnóstico; Tratamento (Atraso no ínicio); Fatores de risco; Câncer de mama; Programas de rastreamento; Mamografia; Epidemiologia; Brasil.; Breast neoplasms; Risk factors; Mammography; Epidemiology; Treatment; Brazil.; Ciências da Saúde; Medicina

Breast cancer is more common in women on Brazil. Excluding non-melanoma skin tumors, the number of new cases increases every year and the death rate has an upward curve. Considering the magnitude of the information presented, screening, diagnosis and treatment related to this neoplasm, arranged on two (2) studies, were the theme of this study. The goal of the first study was to analyze the prevalence and factors that are associated with the achievement of annual mammography in women over 40 years. It is a cross-sectional and retrospective study that was done in a reference center in oncology, Parana / Brazil, from October 2013 to October 2014, with 525 women aged 40 and above 70 years. The prevalence of annual achievement was verified among 54.1% women; the annual mammographic screening was seen among women who did not have any health insurance, used hormone replacement therapy and contraceptive pill in the past; for those women who did not perform the clinical examination and breast self-exam, they were associated with non-performance tracking. Related to the second study, the proposal was to analyze the factors on delay to start of the breast cancer treatment among women who are seen in a referral service. The retrospective and cross-sectional study was conducted with collected data from prompt-books and interviews with women that carry breast malignancy, who were treated from October 2013 to October 2014 in an oncology reference unit in Parana, southern Brazil. During that period, 82 patients with average age of 58.23 ± 11.55 years were evaluated. A total of 63.4% of women had delays in starting to the treatment and the average time for the treatment delay was 87.30 ± 65.57 days; women with low education were more likely to delay the treatment. Data from the study revealed the need for preventive strategies and screening actions to diagnose too early the disease and implement the access to the treatment too soon.